Dinesh Elumalai explores the prospects of integrating Artificial Intelligence in India's medical sector to develop tomorrow's infrastructure The use of artificial intelligence (AI) in business and now in healthcare is widespread. The growth of healthcare data suggests that the use of artificial intelligence is growing. Early disease diagnosis, the development of new drugs, drug testing, diabetic retinopathy, cancer therapies, cardiovascular disease, and eye care are the main applications of AI. India is expected to invest $11.78 billion in AI by 2025. It is anticipated to have boosted India's economy by $1 trillion by 2035.

If we are talking about intelligence framing the reference of Artificial Intelligence in the healthcare sector, then definitely the sky is the limit. AI in healthcare has been setting benchmarks for itself to grow at a consistent pace. Taking a look at healthcare startups, AI healthcare startups have boomed and how. Still, many healthcare startups are unaware of the fact what wonders artificial intelligence can do for their venture. So, that being said, why don't we talk about the current scenario of AI in healthcare? We will be covering everything about this concept from scratch; the transformations it has brought, the challenges to implementing AI in healthcare, the benefits it has offered, and other significant stuff. Let's brew this conversation with a cup of brewed coffee! We all are aware of the fact AI in healthcare is being embraced relatively, especially AI. Many healthcare startups have claimed to witness major differences after implementing AI solutions.

The most creative healthcare companies nowadays incorporate the power of artificial intelligence (AI) into their service. Many startups have been gradually shifting into health technology, so those in need will benefit from the advancement of innovation in the medical field. For now, let's get to know some of the healthcare startups, which have been devising the most updated AI systems to date. According to the latest list from CB Insights, the world is currently composed of 100 AI startups that cover a lot of specialization from science to virus modeling. So much for this part, we will only focus on the healthcare industries where the notable firms have been slowly recognized.

Dmitry Kaminskiy speaks as though he were trying to unload everything he knows about the science and economics of longevity--from senolytics research that seeks to stop aging cells from spewing inflammatory proteins and other molecules to the trillion-dollar life extension industry that he and his colleagues are trying to foster--in one sitting. At the heart of the discussion with Singularity Hub is the idea that artificial intelligence will be the engine that drives breakthroughs in how we approach healthcare and healthy aging--a concept with little traction even just five years ago. "At that time, it was considered too futuristic that artificial intelligence and data science … might be more accurate compared to any hypothesis of human doctors," said Kaminskiy, co-founder and managing partner at Deep Knowledge Ventures, an investment firm that is betting big on AI and longevity. Artificial intelligence in healthcare is attracting more investments and deals than just about any sector of the economy, according to data research firm CB Insights. In the most recent third quarter, AI healthcare startups raised nearly $1.6 billion, buoyed by a $550 million mega-round from London-based Babylon Health, which uses AI to collect data from patients, analyze the information, find comparable matches, then make recommendations.

It's no secret that big tech companies like Amazon (AMZN), Microsoft (MSFT), and Alphabet (GOOG), the parent company of Google, are investing in digital healthcare. The market opportunity is pretty enticing when you consider that the U.S. alone spent $3.65 trillion on healthcare just last year. Google made the latest headline-grabbing move when it announced that it would buy wearables-maker Fitbit (FIT) in a deal valued at $2.1 billion. Analysts have noted that the acquisition is part of the company's overall strategy to build an ambient intelligent system where Google is omnipresent. Another motive behind the purchase – pending regulatory approvals – is that Fitbit gives Google access to a treasure trove of healthcare data that it can feed to its London-based AI lab DeepMind or its life sciences subsidiary Verily, which is already collaborating on at least one AI healthcare device for remote patient monitoring.

It's no secret that big tech companies like Amazon (AMZN), Microsoft (MSFT), and Alphabet (GOOG), the parent company of Google, are investing in digital healthcare. The market opportunity is pretty enticing when you consider that the U.S. alone spent $3.65 trillion on healthcare just last year. Google made the latest headline-grabbing move when it announced that it would buy wearables maker Fitbit (FIT) in a deal valued at $2.1 billion. Analysts have noted that the acquisition is part of the company's overall strategy to build an ambient intelligent system where Google is omnipresent. Another motive behind the purchase – pending regulatory approvals – is that Fitbit gives Google access to a treasure trove of healthcare data that it can feed to its London-based AI lab DeepMind or its life sciences subsidiary Verily, which is already collaborating on at least one AI healthcare device for remote patient monitoring.

The world seems more divided today than ever, whether we're talking about politics or the questionable art form of twerking. However, there's one thing we can all agree on: cancer sucks. Nearly 40% of us will receive the dreaded diagnosis at some point in our lives, according to the National Cancer Institute. That's one reason why we've spent quite a bit of time writing about the topic, particularly the different technologies being developed to detect various forms of the disease. It's really a no-brainer: Data from Cancer Research UK suggests 80% of patients survive for at least 10 years after being diagnosed in the early stages of eight of the most common cancers.

Investing in emerging technologies can be extremely risky. It can also be extremely rewarding – and not just for your bank account. Technologies like artificial intelligence have the potential to change the world in many different ways. One of the industries where AI is already making real advances is healthcare, such as the ability to design and validate drug candidates to treat disease in less than two months. That has attracted the attention of plenty of deep-pocketed investors into AI healthcare startups, which have made more deals than any other AI industry since 2014, according to research firm CB Insights, with more than 80 AI diagnostics and medical imaging companies leading the way across 150 deals and counting.